Literature DB >> 25806252

Alternatives to surgery in early stage disease-stereotactic body radiotherapy.

Meredith Elana Giuliani1, Andrea Bezjak1.   

Abstract

The management of early stage non-small cell lung carcinoma (NSCLC) has been revolutionized by the introduction of stereotactic body radiotherapy (SBRT). SBRT is now the standard of care for medically inoperable patients with early stage NSCLC. However, the role of SBRT in medically operable patients remains controversial. This article will review the indications, the technical considerations, image guidance principles, potential toxicities and special circumstances in lung SBRT.

Entities:  

Keywords:  Local control; non-small cell lung carcinoma; stereotactic ablative radiotherapy; stereotactic body radiotherapy; toxicity

Year:  2013        PMID： 25806252      PMCID： PMC4367723          DOI： 10.3978/j.issn.2218-6751.2013.10.10

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


  37 in total

1.  Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit.

Authors:  M Uematsu; A Shioda; A Suda; K Tahara; T Kojima; Y Hama; M Kono; J R Wong; T Fukui; S Kusano
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-09-01       Impact factor: 7.038

2.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

3.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

4.  Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States.

Authors:  Megan E Daly; Julian R Perks; Allen M Chen
Journal:  J Thorac Oncol       Date:  2013-02       Impact factor: 15.609

5.  Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame.

Authors:  J Wulf; U Hädinger; U Oppitz; B Olshausen; M Flentje
Journal:  Radiother Oncol       Date:  2000-11       Impact factor: 6.280

6.  Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.

Authors:  Mojgan Taremi; Andrew Hope; Max Dahele; Shannon Pearson; Sharon Fung; Thomas Purdie; Anthony Brade; John Cho; Alexander Sun; Jean-Pierre Bissonnette; Andrea Bezjak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

7.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients.

Authors:  H Blomgren; I Lax; I Näslund; R Svanström
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

8.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.

Authors:  Inga S Grills; Victor S Mangona; Robert Welsh; Gary Chmielewski; Erika McInerney; Shannon Martin; Jennifer Wloch; Hong Ye; Larry L Kestin
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

9.  Natural history of stage I non-small cell lung cancer: implications for early detection.

Authors:  Dan J Raz; Jason A Zell; S-H Ignatius Ou; David R Gandara; Hoda Anton-Culver; David M Jablons
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410

10.  Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.

Authors:  Mojgan Taremi; Andrew Hope; Patricia Lindsay; Max Dahele; Sharon Fung; Thomas G Purdie; David Jaffray; Laura Dawson; Andrea Bezjak
Journal:  Radiat Oncol       Date:  2012-09-17       Impact factor: 3.481
View more
  2 in total

1.  Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung Cancer.

Authors:  Julie K Jang; Scott M Atay; Li Ding; Elizabeth A David; Sean C Wightman; Anthony W Kim; Jason C Ye
Journal:  Am J Clin Oncol       Date:  2022-04-01       Impact factor: 2.339

2.  A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer.

Authors:  Can Li; Li Wang; Qian Wu; Jiani Zhao; Fengming Yi; Jianjun Xu; Yiping Wei; Wenxiong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.